Implantable Cardioverter-Defibrillator(ICD) Therapy in a Patient with the Long QT Syndrome

1996 ◽  
Vol 26 (6) ◽  
pp. 1198 ◽  
Author(s):  
Kee-Joon Choi ◽  
Cheol-Whan Lee ◽  
Jae-Joong Kim ◽  
You-Ho Kim
EP Europace ◽  
2018 ◽  
Vol 21 (2) ◽  
pp. 339-346 ◽  
Author(s):  
Yitschak Biton ◽  
Spencer Rosero ◽  
Arthur J Moss ◽  
Ilan Goldenberg ◽  
Valentina Kutyifa ◽  
...  

2003 ◽  
Vol 14 (4) ◽  
pp. 337-341 ◽  
Author(s):  
WOJCIECH ZAREBA ◽  
ARTHUR J. MOSS ◽  
JAMES P. DAUBERT ◽  
W. JACKSON HALL ◽  
JENNIFER L. ROBINSON ◽  
...  

2014 ◽  
Vol 20 (1) ◽  
pp. 1-4
Author(s):  
Sandra Kutkiene˙ ◽  
Lina Gumbiene ◽  
Juratę Aganauskiene ◽  
Rima Steponenienea ◽  
Germanas Marinskisa ◽  
...  

Summary Implantable cardioverters-defibrillators have decreasedmorbidity and mortality as well as improved quality of life in patients with life-threatening cardiac arrhythmias and allowed an increasing number of young women to reach their reproductive years. New questions and tasks arise for medical professionals as to organize appropriate management of these patients, because little is known regarding the risk and outcomes of such pregnancies. The aim of this report is to describe our centre’s first experience of pregnancy and delivery management in patient with an implantable cardioverter-defibrillator as primary prevention of ventricular arrhythmias in congenital long QT syndrome.


Sign in / Sign up

Export Citation Format

Share Document